IP Library › Assignment 034160/0613
Patent Assignment
Reel/Frame 034160/0613

Change of Name

Recorded: 2014-11-04 Pages: 6
Assignor
Assignee
SUMITOMO DAINIPPON PHARMA CO., LTD.
6-8, DOSHO-MACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-8524, JAPAN
Covered Property (1)
Method of Treating Cancer with an RPN2 Gene Expression Inhibitor
Patent: 8,106,024 →
Application: 12/304,888 →
Publication: US 2010/0087507
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 15, 2009
From: OCHIYA, TAKAHIRO; KATO, KIKUYA; HONMA, KIMI; UEDA, YASUJI
To: TAISHO PHARMACEUTICAL CO., LTD.; DAINIPPON SUMITOMO PHARMA CO., LTD.; JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CANCER CENTER; KOKEN CO., LTD.
Reel/Frame 022692/0384 →
Change of Address Jan 24, 2023
From: SUMITOMO PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 062475/0509 →
Change of Name Jan 24, 2023
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 063753/0826 →